Report Detail
Total Artificial Heart - Medical Devices Pipeline Assessment, 2019
- RnM3864397 |
- 10 January, 2020 |
- Global |
- 68 Pages |
- GlobalData |
- Medical Devices & Consumables
Total Artificial Heart - Medical Devices Pipeline Assessment, 2019
Summary
GlobalData's Medical Devices sector report, “Total Artificial Heart - Medical Devices Pipeline Assessment, 2019" provides an overview of Total Artificial Heart currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Total Artificial Heart pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Total Artificial Heart under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Total Artificial Heart and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Total Artificial Heart under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
- 1.1 List of Tables 4
- 1.2 List of Figures 5
2 Introduction 6
- 2.1 Total Artificial Heart Overview 6
3 Products under Development 7
- 3.1 Total Artificial Heart - Pipeline Products by Stage of Development 7
- 3.2 Total Artificial Heart - Pipeline Products by Territory 8
- 3.3 Total Artificial Heart - Pipeline Products by Regulatory Path 9
- 3.4 Total Artificial Heart - Pipeline Products by Estimated Approval Date 10
- 3.5 Total Artificial Heart - Ongoing Clinical Trials 11
4 Total Artificial Heart - Pipeline Products under Development by Companies 12
- 4.1 Total Artificial Heart Companies - Pipeline Products by Stage of Development 12
- 4.2 Total Artificial Heart - Pipeline Products by Stage of Development 13
5 Total Artificial Heart Companies and Product Overview 14
- 5.1 Abiomed Inc Company Overview 14
- 5.1.1 Abiomed Inc Pipeline Products & Ongoing Clinical Trials Overview 14
- 5.2 BiVacor Pty Ltd Company Overview 15
- 5.2.1 BiVacor Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 15
- 5.3 Carmat SAS Company Overview 16
- 5.3.1 Carmat SAS Pipeline Products & Ongoing Clinical Trials Overview 16
- 5.4 Cleveland Clinic Lerner College of Medicine Company Overview 20
- 5.4.1 Cleveland Clinic Lerner College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 20
- 5.5 Cleveland Heart Inc Company Overview 22
- 5.5.1 Cleveland Heart Inc Pipeline Products & Ongoing Clinical Trials Overview 22
- 5.6 Foster-Miller Inc (Inactive) Company Overview 23
- 5.6.1 Foster-Miller Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 23
- 5.7 Indian Institute of Technology Kharagpur Company Overview 24
- 5.7.1 Indian Institute of Technology Kharagpur Pipeline Products & Ongoing Clinical Trials Overview 24
- 5.8 Lausanne University Hospital Company Overview 25
- 5.8.1 Lausanne University Hospital Pipeline Products & Ongoing Clinical Trials Overview 25
- 5.9 OregonHeart Inc (Inactive) Company Overview 26
- 5.9.1 OregonHeart Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 26
- 5.10 ReliantHeart, Inc. Company Overview 27
- 5.10.1 ReliantHeart, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
- 5.11 Scandinavian Real Heart AB Company Overview 28
- 5.11.1 Scandinavian Real Heart AB Pipeline Products & Ongoing Clinical Trials Overview 28
- 5.12 Syncardia Systems LLC Company Overview 29
- 5.12.1 Syncardia Systems LLC Pipeline Products & Ongoing Clinical Trials Overview 29
- 5.13 TEDA International Cardiovascular Hospital Company Overview 36
- 5.13.1 TEDA International Cardiovascular Hospital Pipeline Products & Ongoing Clinical Trials Overview 36
- 5.14 University of Tokyo Company Overview 37
- 5.14.1 University of Tokyo Pipeline Products & Ongoing Clinical Trials Overview 37
- 5.15 Yale University Company Overview 38
- 5.15.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview 38
6 Total Artificial Heart- Recent Developments 39
- 6.1 Nov 27, 2019: CARMAT appoints Alexandre Eleonore as director of manufacturing 39
- 6.2 Nov 19, 2019: CARMAT granted authorization to resume the PIVOTAL study in the Czech Republic 39
- 6.3 Nov 13, 2019: Micron Solutions reports 2019 third quarter results 40
- 6.4 Nov 06, 2019: CARMAT: the feedback after 6 years and 8 months of cumulative support shows a constant improvement in the clinical outcomes of patients in the PIVOTAL study 40
- 6.5 Oct 31, 2019: Abiomed announces Q2 FY 2020 revenue of $205 million and 29.4% operating margin 41
7 Appendix 65
- 7.1 Methodology 65
- 7.2 About GlobalData 68
- 7.3 Contact Us 68
Summary:
Get latest Market Research Reports on Total Artificial Heart. Industry analysis & Market Report on Total Artificial Heart is a syndicated market report, published as Total Artificial Heart - Medical Devices Pipeline Assessment, 2019. It is complete Research Study and Industry Analysis of Total Artificial Heart market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
